Armistice Capital, LLC Fibrogen Inc Transaction History
Armistice Capital, LLC
- $6.02 Billion
- Q3 2024
A detailed history of Armistice Capital, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 6,800,000 shares of FGEN stock, worth $2.38 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,800,000
Previous 8,936,000
23.9%
Holding current value
$2.38 Million
Previous $7.95 Million
65.8%
% of portfolio
0.05%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding FGEN
# of Institutions
82Shares Held
47.1MCall Options Held
387KPut Options Held
672K-
Primecap Management CO Pasadena, CA9.91MShares$3.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.88MShares$2.06 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$843,3770.0% of portfolio
-
683 Capital Management, LLC New York, NY2.14MShares$748,4400.08% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $32.8M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...